Medtronic PLC (MDT)vsNeogen Corporation (NEOG)
MDT
Medtronic PLC
$94.78
+2.46%
HEALTHCARE · Cap: $121.20B
NEOG
Neogen Corporation
$12.26
+1.16%
HEALTHCARE · Cap: $2.58B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 4147% more annual revenue ($37.54B vs $884.00M). MDT leads profitability with a 13.9% profit margin vs -6.3%. NEOG appears more attractively valued with a PEG of 0.66. MDT earns a higher WallStSmart Score of 68/100 (B-).
MDT
Strong Buy68
out of 100
Grade: B-
NEOG
Hold44
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-0.7%
Fair Value
$94.08
Current Price
$94.78
$0.70 premium
Margin of Safety
+80.7%
Fair Value
$55.64
Current Price
$12.26
$43.38 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Earnings expanding 40.7% YoY
Generating 1.3B in free cash flow
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
Expensive relative to growth rate
Grey zone — moderate risk
ROE of -29.0% — below average capital efficiency
Earnings declined 85.6%
Distress zone — elevated risk
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, EPS Growth. Revenue growth of 13.7% demonstrates continued momentum.
Bull Case : NEOG
The strongest argument for NEOG centers on Price/Book, PEG Ratio. PEG of 0.66 suggests the stock is reasonably priced for its growth.
Bear Case : MDT
The primary concerns for MDT are PEG Ratio, Altman Z-Score.
Bear Case : NEOG
The primary concerns for NEOG are Return on Equity, EPS Growth, Altman Z-Score.
Key Dynamics to Monitor
MDT profiles as a value stock while NEOG is a turnaround play — different risk/reward profiles.
NEOG carries more volatility with a beta of 1.79 — expect wider price swings.
MDT is growing revenue faster at 13.7% — sustainability is the question.
MDT generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
MDT scores higher overall (68/100 vs 44/100) and 13.7% revenue growth. NEOG offers better value entry with a 80.7% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Neogen Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?